Medicare Enrolled

Dr. Zack Ramilevich, MD

Neurology · Hollywood, FL
1297 EUCALYPTUS DR, Hollywood, FL 33021
7862881724
Registered in NPPES since 2020
NPI: 1568099851 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ramilevich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramilevich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ramilevich

Dr. Zack Ramilevich is a neurology specialist in Hollywood, FL, with 6 years of NPI registration.

Between the years covered by Open Payments, Dr. Ramilevich received a total of $3,919 from 30 pharmaceutical and/or device companies across 87 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ramilevich is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $3,919 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,919
Total received (2022-2024)
Avg $1,306/year across 3 years
Top 41% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
87
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,429
2023
$465
2022
$25

Payments by company (2024)

ABBVIE INC.
$436
ARGENX US, INC.
$379
Alexion Pharmaceuticals, Inc.
$318
Eisai Inc.
$272
GENZYME CORPORATION
$270
Neurocrine Biosciences, Inc.
$250
ANI Pharmaceuticals, Inc.
$198
Lilly USA, LLC
$170
Teva Pharmaceuticals USA, Inc.
$134
Lundbeck LLC
$131
SK Life Science, Inc.
$96
PFIZER INC.
$85
Merz Pharmaceuticals, LLC
$76
MDD US Operations, LLC
$65
Takeda Pharmaceuticals U.S.A., Inc.
$63
MITSUBISHI TANABE PHARMA AMERICA, INC.
$52
ACADIA Pharmaceuticals Inc
$51
Harmony Biosciences Llc
$50
Biogen, Inc.
$49
CSL Behring
$47
Amneal Pharmaceuticals LLC
$34
REVANCE THERAPEUTICS, INC.
$30
Neurelis, Inc.
$28
Octapharma USA, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$25
Alnylam Pharmaceuticals Inc.
$24
UCB, Inc.
$24
PIRAMAL CRITICAL CARE
$23
JAZZ PHARMACEUTICALS INC.
$21
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2022-2024) ›
Alexion Pharmaceuticals, Inc.
$547
ABBVIE INC.
$436
ARGENX US, INC.
$379
Eisai Inc.
$272
GENZYME CORPORATION
$270
Neurocrine Biosciences, Inc.
$250
SK Life Science, Inc.
$218
ANI Pharmaceuticals, Inc.
$198
Lilly USA, LLC
$170
Teva Pharmaceuticals USA, Inc.
$134
Lundbeck LLC
$131
Jazz Pharmaceuticals Inc.
$115
PFIZER INC.
$85
Merz Pharmaceuticals, LLC
$76
MDD US Operations, LLC
$65
Takeda Pharmaceuticals U.S.A., Inc.
$63
MITSUBISHI TANABE PHARMA AMERICA, INC.
$52
ACADIA Pharmaceuticals Inc
$51
Harmony Biosciences Llc
$50
Biogen, Inc.
$49
CSL Behring
$47
JAZZ PHARMACEUTICALS INC.
$46
Amneal Pharmaceuticals LLC
$34
REVANCE THERAPEUTICS, INC.
$30
Neurelis, Inc.
$28
Octapharma USA, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$25
Alnylam Pharmaceuticals Inc.
$24
UCB, Inc.
$24
PIRAMAL CRITICAL CARE
$23
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
AMYVID · Apokyn · Austedo XR · BOTOX · DAXXIFY · DUOPA · EPIDIOLEX · FIRDAPSE · GABLOFEN · HYQVIA · Hizentra · INGREZZA · KISUNLA · Leqembi · NUPLAZID · NURTEC ODT · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · SKYCLARYS · TYSABRI · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART HYTRULO · WAKIX · XCOPRI · Xeomin · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Hollywood?
Compare neurologists in the Hollywood area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
327
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
MEMORIAL REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ramilevich is a neurology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Ramilevich receive payments from pharmaceutical companies?
Yes. Dr. Ramilevich received a total of $3,919 from 30 companies across 87 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Ramilevich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →